AMCGX
Price
$10.26
Change
-$0.06 (-0.58%)
Updated
Jan 24 closing price
Net Assets
255M
PMAQX
Price
$46.42
Change
+$0.01 (+0.02%)
Updated
Jan 24 closing price
Net Assets
29.98B
Ad is loading...

AMCGX vs PMAQX

Header iconAMCGX vs PMAQX Comparison
Open Charts AMCGX vs PMAQXBanner chart's image
Alger Mid Cap Growth B
Price$10.26
Change-$0.06 (-0.58%)
VolumeN/A
Net Assets255M
Principal MidCap R6
Price$46.42
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets29.98B
AMCGX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMCGX vs. PMAQX commentary
Jan 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCGX is a StrongBuy and PMAQX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30B vs. AMCGX (255M). PMAQX pays higher dividends than AMCGX: PMAQX (0.10) vs AMCGX (0.00). AMCGX was incepted earlier than PMAQX: AMCGX (32 years) vs PMAQX (8 years). AMCGX is a more actively managed with annual turnover of: 78.35 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than AMCGX: PMAQX (0) vs AMCGX (1000). AMCGX annual gain was more profitable for investors over the last year : 26.67 vs. PMAQX (19.48). PMAQX return over 5 years is better than : 44.43 vs. AMCGX (-7.99).
AMCGXPMAQXAMCGX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years8 years-
Gain YTD6.6534.011166%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets255M30B1%
Annual Yield % from dividends0.000.10-
Returns for 1 year26.6719.48137%
Returns for 3 years26.5128.3993%
Returns for 5 years-7.9944.43-18%
Returns for 10 years20.68N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BXP73.561.70
+2.37%
BXP Inc.
PSEC4.380.01
+0.23%
Prospect Capital Corp
LWLG1.97-0.02
-1.01%
Lightwave Logic
ZVSA1.48-0.03
-1.93%
ZyVersa Therapeutics
SSSS6.31-0.22
-3.37%
SuRo Capital Corp